SCOPE AND OBJECTIVES OF THE REPORT
This report pulls together and presents the most up-to-date information about
the use of transgenic plants and crops to develop and mass-produce human
therapeutics.
Amongst other questions, this report seeks to answer the following
questions:
- What is plant molecular farming, or biopharming?
- How large is the world market potential for this biotechnology?
- What are the technical, regulatory, and intellectual property issues in
this sector?
- What are the public relations and communications concerns?
- What pharmaceutical products are in the pipeline?
- Who are the major players working in this area?
This report is designed to be an informational tool for analysts, business
strategists, and technology developers in the pharmaceutical,
agrobiotechnological, and biological sectors.
It will give plant biotechnologists valuable insight into the value of and
potential markets for their achievements and enlighten producers looking for
alternative added-value routes for their agricultural efforts, as well as
provide valuable information for process and product developers looking for
lower-cost manufacturing systems for biotechnology-derived pharmaceuticals and
biologics.
View Cart
